Perspective · 25 Feb 2026
Conference abstractPublished 23 Nov 2012
Analytical software for clinical trials
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Clinical trials often involve patients with specific health conditions who then benefit from receiving otherwise unavailable treatments. Study subjects typically remain on site at the unit for durations of one to 30 nights, and occasionally longer, although this is not always the case. Clinical Trial is conducted to gain insights for design of the clinical trial to follow effectiveness is how well a treatment works in practice and efficacy is how well it works in a clinical trial. The investigators observe the subjects and measure their outcomes & give the research subjects a particular medicine or other intervention. Clinical trial protocol: Describes the scientific rationale, objective(s), design, methodology, statistical considerations, and organization of the planned trial. Protocol contains a precise study plan for executing the clinical trial, not only to assure safety and health of the trial subjects, but also to provide an exact template for trial conduct by investigators at multiple locations. Clinical trials involving new drugs are commonly classified into four phases as Phase I, II, III, IV. The drug-development process will normally proceed through all four phases over many years. If the drug successfully passes through Phases 1, 2, and 3, it will usually be approved by the national regulatory authority for use in the general population. The protocol contains a precise study plan for executing the clinical trial, not only to assure safety and health of the trial subjects, but also to provide an exact template for trial conduct by investigators at multiple locations (in a "multicenter" trial) to perform the study in exactly the same way. The protocol also gives the study administrators, the site team of physicians, nurses and clinic administrators, a common reference document for site responsibilities during the trial. Clinical data management system: CDMS is a tool used in clinical research to manage the data of a clinical trial. The clinical trial data gathered at the investigator site in the Case Report Form are stored in the CDMS. To reduce the possibility of errors due to human entry, the systems employ various means to verify the data. The most popular method being double data entry where two different data entry operators enter the data in the system independently and both the entries are compared by the system. CDMS can perform is the coding of data. Currently, the coding is generally centered around two areas ? adverse event terms and medication names.The system can check the data in the CDMS and compare them to the dictionaries. Items that do not match can be flagged for further checking. Some systems allow for the storage of synonyms to allow the system to match common abbreviations and map them to the correct term.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract
Review of the softwares used in pharmacovigilance and clinical trials
Conference abstract
Real-time EHR-based patient data analytics for the acceleration of clinical trial recruitment
Article · 26 Dec 2024
Analytical techniques for Bioequivalence Trial Drug Absorption Evaluation and Generic Medications
Short communication · 29 Nov 2023
Streamlining Healthcare with Clinical Software and Data Management
More from this journal
The newest in Pharmaceutical Regulatory Affairs: Open Access.
Article · 13 Feb 2026
Regulatory Scenario of Pharmaceuticals during COVID-19 Pandemic in India
Article · 11 Feb 2026
EU GMP Annex 1 of 2022: A View in Depth
Article · 11 Feb 2026
Standard Formats Used in Drug Regulatory Submissions and Software Used
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutical Regulatory Affairs: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “K. Ramesh Kumar”
- BylineArticles whose byline prints “Swetha G”

